首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1489214

全球體外受精市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global In Vitro Fertilization Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球體外受精市場需求預計將從 2023 年的 7.8289 億美元增至 2032 年的近 14.9472 億美元，2024-2032 年研究期間複合年成長率為 7.45%。

體外受精（IVF）是一種用於幫助不孕症的個人或夫婦實現懷孕的生殖技術。它包括在實驗室環境中在體外用精子使卵子受精，並將所得胚胎移植到子宮中。建議體外受精的原因可能有多種，包括輸卵管阻塞、男性不孕、高齡產婦或不明原因不孕。這個過程通常包括卵巢刺激以產生多個卵子、透過經陰道超音波引導抽吸取卵、在培養皿中使取出的卵子受精、胚胎培養和選擇以及胚胎移植。體外受精為面臨自然受孕挑戰的個人帶來了希望，其成功率受年齡、生殖健康和治療方案等因素的影響。

市場動態

由於孕產婦年齡成長、生活方式改變和生殖健康障礙等因素，全球不孕症盛行率不斷上升，推動了對體外受精的需求。隨著夫妻和個人尋求克服不孕症挑戰的解決方案，試管受精手術為懷孕提供了可行的選擇。此外，體外受精技術、實驗室方案和胚胎培養系統的進步提高了成功率和結果，增強了人們對體外受精作為治療選擇的信心。此外，IVF 服務範圍的不斷擴大，包括植入前基因檢測 (PGT)、卵子冷凍和胚胎選擇技術，正在擴大市場吸引力並推動不同患者群體的採用。此外，LGBTQ+夫婦、選擇的單親父母以及推遲生育的個人對試管受精手術的接受度不斷提高，這正在擴大市場潛力，並推動生育治療和服務的創新。然而，有關使用輔助生殖技術的監管限制和倫理考慮，以及體外受精治療的高成本，可能會挑戰未來幾年體外受精市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球體外受精市場的各個細分市場進行了包容性評估。體外受精產業的成長和趨勢為本研究提供了整體方法。

市場區隔

體外受精市場報告的這一部分提供了有關國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

裝置
試劑和介質
配件

按週期

新的非捐款週期
冷凍非供體 IVF 週期
冷凍供體 IVF 週期
新鮮捐贈者 IVF 週期

按類型

傳統體外受精
IVF 與 ICSI
使用捐贈卵子進行體外受精

按最終用戶

生育診所
醫院及手術中心
冷凍庫和研究所

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲體外受精市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。體外受精市場的主要參與者包括 Vitrolife AB、Cook Medical、Thermo Fisher Scientific Inc.、Merck KGAA、Ovascience Inc.、CooperSurgical、EMD Serono Inc.、Genea Ltd.、Rocket Medical PLC、Fertility Focus Ltd.。格局的整體看法，包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按產品分類的市場吸引力分析
- 按週期的市場吸引力分析
- 按類型分類的市場吸引力分析
- 最終用戶的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球體外受精市場分析：依產品分類

概述（按產品）
歷史和預測數據
按產品分析
裝置
試劑和介質
配件

第 6 章：全球體外受精市場分析：按週期

按週期概覽
歷史和預測數據
按週期分析
新的非捐款週期
冷凍非供體 IVF 週期
冷凍供體 IVF 週期
新鮮捐贈者 IVF 週期

第 7 章：全球體外受精市場分析：按類型

按類型概述
歷史和預測數據
按類型分析
傳統體外受精
IVF 與 ICSI
使用捐贈卵子進行體外受精

第 8 章：全球體外受精市場分析：依最終使用者分類

最終用戶概述
歷史和預測數據
最終用戶分析
生育診所
醫院及手術中心
冷凍庫和研究所

第 9 章：全球體外受精市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：體外受精公司的競爭格局

體外受精市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Vitrolife AB

公司簡介
公司收入
產品
最近的發展

Cook Medical

公司簡介
公司收入
產品
最近的發展

Thermo Fisher Scientific Inc.

公司簡介
公司收入
產品
最近的發展

Merck KGAA

公司簡介
公司收入
產品
最近的發展

Ovascience Inc.

公司簡介
公司收入
產品
最近的發展

CooperSurgical

公司簡介
公司收入
產品
最近的發展

EMD Serono Inc.

公司簡介
公司收入
產品
最近的發展

Genea Ltd.

公司簡介
公司收入
產品
最近的發展

Rocket Medical PLC

公司簡介
公司收入
產品
最近的發展

Fertility Focus Ltd

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114516

The global demand for In Vitro Fertilization Market is presumed to reach the market size of nearly USD 1494.72 Million by 2032 from USD 782.89 Million in 2023 with a CAGR of 7.45% under the study period 2024-2032.

In vitro fertilization (IVF) represents a reproductive technology used to assist individuals or couples with infertility in achieving pregnancy. It includes fertilizing an egg with sperm outside the body in a laboratory setting and transferring the resulting embryos into the uterus. IVF may be recommended for different reasons, including blocked fallopian tubes, male infertility, advanced maternal age, or unexplained infertility. The process typically includes ovarian stimulation to produce multiple eggs, egg retrieval via transvaginal ultrasound-guided aspiration, fertilization of retrieved eggs in a culture dish, embryo culture and selection, and embryo transfer. IVF offers hope for individuals facing challenges conceiving naturally, with success rates influenced by factors such as age, reproductive health, and treatment protocols.

MARKET DYNAMICS

The increasing prevalence of infertility worldwide, attributed to factors such as advancing maternal age, lifestyle changes, and reproductive health disorders, is driving demand for in vitro fertilization. As couples and individuals seek solutions to overcome infertility challenges, IVF procedures offer a viable option for achieving pregnancy. Additionally, advancements in IVF techniques, laboratory protocols, and embryo culture systems have enhanced success rates and outcomes, boosting confidence in IVF as a treatment option. Furthermore, the expanding scope of IVF services, including preimplantation genetic testing (PGT), egg freezing, and embryo selection technologies, is widening the market appeal and driving adoption among diverse patient populations. Moreover, the growing acceptance of IVF procedures among LGBTQ+ couples, single parents by choice, and individuals delaying parenthood is expanding the market potential and driving innovation in fertility treatments and services. However, regulatory restrictions and ethical considerations regarding the use of assisted reproductive technologies, along with the high cost of in vitro fertilization treatments, may challenge the in vitro fertilization market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of In Vitro Fertilization. The growth and trends of In Vitro Fertilization industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the In Vitro Fertilization market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Equipment
Reagents & Media
Accessories

By Cycle

Fresh Non-donor Cycle
Frozen Non-donor IVF Cycle
Frozen Donor IVF Cycle
Fresh Donor IVF Cycle

By Type

Conventional IVF
IVF with ICSI
IVF with Donor Eggs

By End-user

Fertility Clinics
Hospitals & Surgical Centers
Cryobanks & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In Vitro Fertilization market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In Vitro Fertilization market include Vitrolife AB, Cook Medical, Thermo Fisher Scientific Inc., Merck KGAA, Ovascience Inc., CooperSurgical, EMD Serono Inc., Genea Ltd., Rocket Medical PLC, Fertility Focus Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. IN VITRO FERTILIZATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Cycle
- 3.7.3 Market Attractiveness Analysis By Type
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN VITRO FERTILIZATION MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Equipment Historic and Forecast Sales By Regions
5.5. Reagents & Media Historic and Forecast Sales By Regions
5.6. Accessories Historic and Forecast Sales By Regions

6. GLOBAL IN VITRO FERTILIZATION MARKET ANALYSIS BY CYCLE

6.1. Overview By Cycle
6.2. Historical and Forecast Data
6.3. Analysis By Cycle
6.4. Fresh Non-donor Cycle Historic and Forecast Sales By Regions
6.5. Frozen Non-donor IVF Cycle Historic and Forecast Sales By Regions
6.6. Frozen Donor IVF Cycle Historic and Forecast Sales By Regions
6.7. Fresh Donor IVF Cycle Historic and Forecast Sales By Regions

7. GLOBAL IN VITRO FERTILIZATION MARKET ANALYSIS BY TYPE

7.1. Overview By Type
7.2. Historical and Forecast Data
7.3. Analysis By Type
7.4. Conventional IVF Historic and Forecast Sales By Regions
7.5. IVF with ICSI Historic and Forecast Sales By Regions
7.6. IVF with Donor Eggs Historic and Forecast Sales By Regions

8. GLOBAL IN VITRO FERTILIZATION MARKET ANALYSIS BY END-USER

8.1. Overview By End-user
8.2. Historical and Forecast Data
8.3. Analysis By End-user
8.4. Fertility Clinics Historic and Forecast Sales By Regions
8.5. Hospitals & Surgical Centers Historic and Forecast Sales By Regions
8.6. Cryobanks & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL IN VITRO FERTILIZATION MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE IN VITRO FERTILIZATION COMPANIES

10.1. In Vitro Fertilization Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF IN VITRO FERTILIZATION INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Vitrolife AB
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Cook Medical
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Thermo Fisher Scientific Inc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Merck KGAA
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Ovascience Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. CooperSurgical
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. EMD Serono Inc.
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Genea Ltd.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Rocket Medical PLC
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Fertility Focus Ltd
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments